4 Results for "

Donanemab

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Donanemab" in MCE Product Catalog:

Cat. No.: HY-P99859
CAS No.: 1931944-80-7
Synonyms: LY3002813

Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N-terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P991045
Synonyms: mE8‑IgG2a

Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Donanemab (Mouse IgG2a) (mE8-IgG2a) is a mouse-derived IgG2 monoclonal antibody used in the research of Alzheimer's disease.
loading...
    loading...
Cat. No.: HY-P991046

Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Donanemab (Mouse IgG2b) is a chimeric antibody composed of humanized variable regions and a mouse IgG2b backbone. Donanemab (Mouse IgG2b) is an anti-amyloid inhibitor used in Alzheimer's disease research.
loading...
    loading...
Cat. No.: HY-P99859A
CAS No.: 1931944-80-7
Synonyms: LY3002813 (powder)

Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Donanemab (LY3002813) (powder) is a humanized IgG1 monoclonal antibody directed at an N-terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab (powder) has the potential for early Alzheimer's disease research .
loading...
    loading...